HR 3906 Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
Medical Research for Our Troops Act
To amend the Full-Year Continuing Appropriations and Extensions Act, 2025 to restore amounts available for Defense Health Agency research, development, test, and evaluation, including Congressionally Directed Medical Research Programs.
Summary
This bill would increase Defense Health Agency funding for research, development, testing, and evaluation by approximately $1.18 billion, raising the total from $40.4 billion to $41.6 billion by amending the Full-Year Continuing Appropriations and Extensions Act, 2025. The bill specifically protects funding for Congressionally Directed Medical Research Programs and requires that it be implemented consistent with the Consolidated Appropriations Act, 2024. The Secretary of Defense must ensure the funds support all research programs and peer-reviewed initiatives identified in the 2024 appropriations explanatory statement and maintain adherence to specified funding allocations and research priorities.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
- Rep. Carson, André [D-IN-7] (D-IN)
52 cosponsors
- Del. Norton, Eleanor Holmes [D-DC-At Large] (D-DC)
- Rep. Auchincloss, Jake [D-MA-4] (D-MA)
- Rep. Balint, Becca [D-VT-At Large] (D-VT)
- Rep. Barragán, Nanette Diaz [D-CA-44] (D-CA)
- Rep. Beatty, Joyce [D-OH-3] (D-OH)
- Rep. Bell, Wesley [D-MO-1] (D-MO)
- Rep. Bishop, Sanford D. [D-GA-2] (D-GA)
- Rep. Budzinski, Nikki [D-IL-13] (D-IL)
- Rep. Cohen, Steve [D-TN-9] (D-TN)
- Rep. Craig, Angie [D-MN-2] (D-MN)
- Rep. Davids, Sharice [D-KS-3] (D-KS)
- Rep. Davis, Danny K. [D-IL-7] (D-IL)
- Rep. Deluzio, Christopher R. [D-PA-17] (D-PA)
- Rep. Doggett, Lloyd [D-TX-37] (D-TX)
- Rep. Fields, Cleo [D-LA-6] (D-LA)
- Rep. Figures, Shomari [D-AL-2] (D-AL)
- Rep. Foster, Bill [D-IL-11] (D-IL)
- Rep. Garamendi, John [D-CA-8] (D-CA)
- Rep. García, Jesús G. "Chuy" [D-IL-4] (D-IL)
- Rep. Garcia, Sylvia R. [D-TX-29] (D-TX)
- Rep. Goodlander, Maggie [D-NH-2] (D-NH)
- Rep. Gottheimer, Josh [D-NJ-5] (D-NJ)
- Rep. Grijalva, Adelita S. [D-AZ-7] (D-AZ)
- Rep. Horsford, Steven [D-NV-4] (D-NV)
- Rep. Jackson, Jonathan L. [D-IL-1] (D-IL)
- Rep. Johnson, Henry C. "Hank" [D-GA-4] (D-GA)
- Rep. Johnson, Julie [D-TX-32] (D-TX)
- Rep. Levin, Mike [D-CA-49] (D-CA)
- Rep. Lynch, Stephen F. [D-MA-8] (D-MA)
- Rep. Matsui, Doris O. [D-CA-7] (D-CA)
- Rep. McBride, Sarah [D-DE-At Large] (D-DE)
- Rep. McClain Delaney, April [D-MD-6] (D-MD)
- Rep. McGarvey, Morgan [D-KY-3] (D-KY)
- Rep. McIver, LaMonica [D-NJ-10] (D-NJ)
- Rep. Moulton, Seth [D-MA-6] (D-MA)
- Rep. Mrvan, Frank J. [D-IN-1] (D-IN)
- Rep. Neal, Richard E. [D-MA-1] (D-MA)
- Rep. Ocasio-Cortez, Alexandria [D-NY-14] (D-NY)
- Rep. Olszewski, Johnny [D-MD-2] (D-MD)
- Rep. Pettersen, Brittany [D-CO-7] (D-CO)
- Rep. Ross, Deborah K. [D-NC-2] (D-NC)
- Rep. Salinas, Andrea [D-OR-6] (D-OR)
- Rep. Schrier, Kim [D-WA-8] (D-WA)
- Rep. Sewell, Terri A. [D-AL-7] (D-AL)
- Rep. Simon, Lateefah [D-CA-12] (D-CA)
- Rep. Soto, Darren [D-FL-9] (D-FL)
- Rep. Strickland, Marilyn [D-WA-10] (D-WA)
- Rep. Titus, Dina [D-NV-1] (D-NV)
- Rep. Tonko, Paul [D-NY-20] (D-NY)
- Rep. Trahan, Lori [D-MA-3] (D-MA)
- Rep. Williams, Nikema [D-GA-5] (D-GA)
- Rescom. Hernández, Pablo Jose [D-PR-At Large] (D-PR)
Money behind the sponsor
Top reported contributors to André Carson’s campaign committee (2024 cycle) — who funds the bill’s sponsor, not a claim about this bill. Data from FEC.
- ICE MILLER $7,600
- NULL $7,600
- MAGNA PROPERTIES $6,600
- A10 ASSOCIATES $6,600
- AMERICAN CONSULTING $6,200
Organizations whose employees gave the most — itemized individual contributions grouped by the donor’s reported employer (FEC Schedule A). Full finance for André Carson → · Outside spending →
Actions (3)
- Jun 11, 2025 Referred to the House Committee on Appropriations. · house
- Jun 11, 2025 Introduced in House
- Jun 11, 2025 Sponsor introductory remarks on measure. (CR E561)
Similar bills (6)
Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.
Text versions (1)
Bills are re-published as they move (Introduced → Reported → Engrossed → Enrolled …). Each stage below is a separate text; pick two to see what changed. Data from Congress.gov.
Full text
IN THE HOUSE OF REPRESENTATIVES
June 11, 2025
Mr. Carson (for himself, Mr. Auchincloss, Ms. Barragan, Ms. Budzinski, Ms. Craig, Mr. Doggett, Mr. Fields, Ms. Garcia of Texas, Ms. Goodlander, Mr. Gottheimer, Mr. Jackson of Illinois, Mr. Levin, Mr. Lynch, Ms. McBride, Mrs. McIver, Mr. Moulton, Mr. Mrvan, Ms. Ocasio- Cortez, Mr. Neal, Ms. Norton, Ms. Ross, Ms. Salinas, Ms. Schrier, and Ms. Strickland) introduced the following bill; which was referred to the Committee on Appropriations
A BILL
To amend the Full-Year Continuing Appropriations and Extensions Act, 2025 to restore amounts available for Defense Health Agency research, development, test, and evaluation, including Congressionally Directed Medical Research Programs.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the “Medical Research for Our Troops Act”.
SEC. 2. RESTORATION OF AMOUNTS FOR DEFENSE HEALTH AGENCY RESEARCH, DEVELOPMENT, TEST, AND EVALUATION.
(a) In General.—Section 1407(1) of the Full-Year Continuing Appropriations and Extensions Act, 2025 (Public Law 119-4) is amended—
(1) by striking “$40,395,072,000” and inserting “$41,576,684,000”; and
(2) by striking the 23rd comma and all that follows through the period at the end and inserting a period.
(b) Effective Date.—The amendments made by subsection (a) shall take effect as if included in the enactment of the Full-Year Continuing Appropriations and Extensions Act, 2025 (Public Law 119-4).
(c) Congressionally Directed Medical Research Programs.—The funds made available for Congressionally Directed Medical Research Programs pursuant to section 1407(1) of the Full-Year Continuing Appropriations and Extensions Act, 2025 (Public Law 119-4), as amended by subsection
(a), shall be implemented in levels and in a manner consistent with the Consolidated Appropriations Act, 2024 (Public Law 118-47). The Secretary of Defense shall—
(1) ensure that such funds are used to support all research programs, peer-reviewed initiatives, and projects identified in the explanatory statement accompanying the Consolidated Appropriations Act, 2024 (Public Law 118-47); and
(2) obligate and expend such funds in a manner that preserves program continuity, including adherence to all specified funding allocations and research priorities identified on pages 311 through 314 of such explanatory statement. <all>
Comments